Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neurogenic orthostatic hypotension (also referred to as neurogenic OH or nOH) is a rare disorder that is defined as low blood pressure that occurs upon standing. NOH is a sub-type of orthostatic hypotension (OH). With NOH and other forms of orthostatic hypotension, patients experience the same symptoms but for different reasons. NOH only occurs in people with an existing neurologic disease, such as: Multiple system atrophy (MSA), Parkinson's disease, Pure autonomic failure (PAF), Diabetic neuropathy, Dopamine beta hydroxylase (DBH) deficiency.
This report elaborates on the current development of the Neurogenic Orthostatic Hypotension industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sumitomo Pharmaceuticals
Chelsea Therapeutics (Droxidopa)
Shire PLC (ProAmatine®)
By Type:
Parkinson's disease
MSA
PAF
Others
Diabetes
Dopamine beta hydroxylase (DBH) Deficiency
By Application:
Clinic
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neurogenic Orthostatic Hypotension Market Overview 2018-2029
-
1.1 China Neurogenic Orthostatic Hypotension Industry Development Overview
-
1.2 China Neurogenic Orthostatic Hypotension Industry Development History
-
1.3 China Neurogenic Orthostatic Hypotension Industry Market Size (2018-2029)
-
1.4 China Neurogenic Orthostatic Hypotension Market Analysis by Type from Production Side
-
1.4.1 China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Parkinson's disease (2018-2029)
-
1.4.2 China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of MSA (2018-2029)
-
1.4.3 China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of PAF (2018-2029)
-
1.4.4 China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.5 China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Diabetes (2018-2029)
-
1.4.6 China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Dopamine beta hydroxylase (DBH) Deficiency (2018-2029)
-
1.5 China Neurogenic Orthostatic Hypotension Market Analysis by Application from Consumption End
-
1.5.1 China Neurogenic Orthostatic Hypotension Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Neurogenic Orthostatic Hypotension Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Neurogenic Orthostatic Hypotension Market Analysis by Region
-
1.6.1 North China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
Chapter 2 China Neurogenic Orthostatic Hypotension Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neurogenic Orthostatic Hypotension Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neurogenic Orthostatic Hypotension Market Status and Competition Analysis in 2023
-
2.2.3 China Neurogenic Orthostatic Hypotension Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neurogenic Orthostatic Hypotension Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neurogenic Orthostatic Hypotension Industry Development
Chapter 3 Neurogenic Orthostatic HypotensionIndustry Chain Analysis
-
3.1 Neurogenic Orthostatic Hypotension Industry Chain
-
3.2 Neurogenic Orthostatic Hypotension Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neurogenic Orthostatic Hypotension Market
-
3.3 Neurogenic Orthostatic Hypotension Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neurogenic Orthostatic Hypotension Market
Chapter 4 China Neurogenic Orthostatic Hypotension Market, by Type
-
4.1 China Neurogenic Orthostatic Hypotension Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neurogenic Orthostatic Hypotension Total Production Volume and Growth Rate from Production Side
-
4.5 China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate, by Type
-
4.5.1 China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Parkinson's disease
-
4.5.2 China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of MSA
-
4.5.3 China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of PAF
-
4.5.4 China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Others
-
4.5.5 China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Diabetes
-
4.5.6 China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Dopamine beta hydroxylase (DBH) Deficiency
Chapter 5 China Neurogenic Orthostatic Hypotension Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neurogenic Orthostatic Hypotension Total Market Size and Growth Rate from Consumption End
-
5.5 China Neurogenic Orthostatic Hypotension Market Size and Growth Rate, by Application
-
5.5.1 China Neurogenic Orthostatic Hypotension Market Size and Growth Rate of Clinic
-
5.5.2 China Neurogenic Orthostatic Hypotension Market Size and Growth Rate of Hospital
Chapter 6 China Neurogenic Orthostatic Hypotension Market, by Region
-
6.1 China Neurogenic Orthostatic Hypotension Production Volume and Production Value, by Region
-
6.2 China Neurogenic Orthostatic Hypotension Sales Volume and Sales Value, by Region
Chapter 7 North China Neurogenic Orthostatic Hypotension Market Analysis
-
7.1 North China Neurogenic Orthostatic Hypotension Market, by Type
-
7.2 North China Neurogenic Orthostatic Hypotension Market, by Application
Chapter 8 Central China Neurogenic Orthostatic Hypotension Market Analysis
-
8.1 Central China Neurogenic Orthostatic Hypotension Market, by Type
-
8.2 Central China Neurogenic Orthostatic Hypotension Market, by Application
Chapter 9 South China Neurogenic Orthostatic Hypotension Market Analysis
-
9.1 South China Neurogenic Orthostatic Hypotension Market, by Type
-
9.2 South China Neurogenic Orthostatic Hypotension Market, by Application
Chapter 10 East China Neurogenic Orthostatic Hypotension Market Analysis
-
10.1 East China Neurogenic Orthostatic Hypotension Market, by Type
-
10.2 East China Neurogenic Orthostatic Hypotension Market, by Application
Chapter 11 Northeast China Neurogenic Orthostatic Hypotension Market Analysis
-
11.1 Northeast China Neurogenic Orthostatic Hypotension Market, by Type
-
11.2 Northeast China Neurogenic Orthostatic Hypotension Market, by Application
Chapter 12 Southwest China Neurogenic Orthostatic Hypotension Market Analysis
-
12.1 Southwest China Neurogenic Orthostatic Hypotension Market, by Type
-
12.2 Southwest China Neurogenic Orthostatic Hypotension Market, by Application
Chapter 13 Northwest China Neurogenic Orthostatic Hypotension Market Analysis
-
13.1 Northwest China Neurogenic Orthostatic Hypotension Market, by Type
-
13.2 Northwest China Neurogenic Orthostatic Hypotension Market, by Application
Chapter 14 Company Profiles
-
14.1 Sumitomo Pharmaceuticals
-
14.1.1 Sumitomo Pharmaceuticals Company Profile
-
14.1.2 Sumitomo Pharmaceuticals Neurogenic Orthostatic Hypotension Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Chelsea Therapeutics (Droxidopa)
-
14.2.1 Chelsea Therapeutics (Droxidopa) Company Profile
-
14.2.2 Chelsea Therapeutics (Droxidopa) Neurogenic Orthostatic Hypotension Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Shire PLC (ProAmatine®)
-
14.3.1 Shire PLC (ProAmatine®) Company Profile
-
14.3.2 Shire PLC (ProAmatine®) Neurogenic Orthostatic Hypotension Market Performance
-
14.3.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neurogenic Orthostatic Hypotension Industry Research Conclusions
-
15.2 Neurogenic Orthostatic Hypotension Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neurogenic Orthostatic Hypotension Industry Market Size (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Parkinson's disease (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of MSA (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of PAF (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Diabetes (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume, Production Value and Growth Rate of Dopamine beta hydroxylase (DBH) Deficiency (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Neurogenic Orthostatic Hypotension Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
Figure Central China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
Figure South China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
Figure East China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neurogenic Orthostatic Hypotension Market Size and Growth Rate from 2018-2029
-
Figure Neurogenic Orthostatic Hypotension Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neurogenic Orthostatic Hypotension Market Share by Type in 2018
-
Figure China Neurogenic Orthostatic Hypotension Market Share by Type in 2023
-
Figure China Neurogenic Orthostatic Hypotension Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Parkinson's disease (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of MSA (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of PAF (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Diabetes (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume and Growth Rate of Dopamine beta hydroxylase (DBH) Deficiency (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Market Share by Application in 2018
-
Figure China Neurogenic Orthostatic Hypotension Market Share by Application in 2023
-
Figure China Neurogenic Orthostatic Hypotension Total Market Size and Growth Rate from Consumption End
-
Figure China Neurogenic Orthostatic Hypotension Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Production Volume by Region (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Production Volume Share by Region (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Volume Share by Region (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Production Value by Region (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Production Value Share by Region (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Production Value Share by Region (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Sales Volume by Region (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Sales Volume Share by Region (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Sales Volume Share by Region (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Sales Value by Region (2018-2023)
-
Table China Neurogenic Orthostatic Hypotension Sales Value Share by Region (2018-2023)
-
Figure China Neurogenic Orthostatic Hypotension Sales Value Share by Region (2018-2023)
-
Table North China Neurogenic Orthostatic Hypotension Production Volume by Type (2018-2023)
-
Table North China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Figure North China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Table North China Neurogenic Orthostatic Hypotension Sales Volume by Application (2018-2023)
-
Table North China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Figure North China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Table Central China Neurogenic Orthostatic Hypotension Production Volume by Type (2018-2023)
-
Table Central China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Figure Central China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Table Central China Neurogenic Orthostatic Hypotension Sales Volume by Application (2018-2023)
-
Table Central China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Figure Central China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Table South China Neurogenic Orthostatic Hypotension Production Volume by Type (2018-2023)
-
Table South China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Figure South China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Table South China Neurogenic Orthostatic Hypotension Sales Volume by Application (2018-2023)
-
Table South China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Figure South China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Table East China Neurogenic Orthostatic Hypotension Production Volume by Type (2018-2023)
-
Table East China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Figure East China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Table East China Neurogenic Orthostatic Hypotension Sales Volume by Application (2018-2023)
-
Table East China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Figure East China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neurogenic Orthostatic Hypotension Production Volume by Type (2018-2023)
-
Table Northeast China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Table Northeast China Neurogenic Orthostatic Hypotension Sales Volume by Application (2018-2023)
-
Table Northeast China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neurogenic Orthostatic Hypotension Production Volume by Type (2018-2023)
-
Table Southwest China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Table Southwest China Neurogenic Orthostatic Hypotension Sales Volume by Application (2018-2023)
-
Table Southwest China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neurogenic Orthostatic Hypotension Production Volume by Type (2018-2023)
-
Table Northwest China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neurogenic Orthostatic Hypotension Production Volume Share by Type (2018-2023)
-
Table Northwest China Neurogenic Orthostatic Hypotension Sales Volume by Application (2018-2023)
-
Table Northwest China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neurogenic Orthostatic Hypotension Sales Volume Share by Application (2018-2023)
-
Table Sumitomo Pharmaceuticals Company Profile
-
Table Sumitomo Pharmaceuticals Neurogenic Orthostatic Hypotension Revenue, Price and Gross (2018-2023)
-
Table Chelsea Therapeutics (Droxidopa) Company Profile
-
Table Chelsea Therapeutics (Droxidopa) Neurogenic Orthostatic Hypotension Revenue, Price and Gross (2018-2023)
-
Table Shire PLC (ProAmatine®) Company Profile
-
Table Shire PLC (ProAmatine®) Neurogenic Orthostatic Hypotension Revenue, Price and Gross (2018-2023)
-
